Furthermore, TK-A3 and TK-A4 (anti HER3 humanized antibodies) have been investigated for their anti-tumor activity against BxPC3 (pancreatic) and some genetically engineered (GEM) models [87]. Here, ERBB3 is linked to neoplasm.